ArticlePloS one2026
A biologically constrained agent-based model of cancer stem cell dynamics with reinforcement learning-guided adaptive radiotherapy.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer stem cells (CSCs) represent a rare but critical subpopulation within tumors, driving recurrence, resistance to therapy, and aggressive growth. To better understand CSC behavior in solid tumors, we developed a biologically constrained agent-based model (ABM) that simulates tumor progression initiated from a single CSC. The model incorporates essential microenvironmental factors-including oxygen diffusion, spatial limitations, stochastic migration, and cell cycle dynamics-allowing for high-resolution simulation of tumor development and intra tumoral heterogeneity. While this work does not aim to fully optimize therapy for clinical application, it provides a flexible, scalable simulation environment where adaptive treatment strategies can be tested. To extend a biological model toward intelligent treatment, we integrated a reinforcement learning (Q-learning) component that adaptively adjusts radiation dosage based on real-time CSC localization and microenvironmental feedback. This component is currently presented as a proof-of-concept to demonstrate feasibility, and its optimization and convergence analysis will be explored in future studies. Our results suggest that reinforcement learning, when integrated with a biologically grounded ABM, can guide adaptive and more personalized radiotherapy strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.